Amaç: Akut pankreatit, önemli komplikasyonlar ve yüksek mortalite ile seyredebilen bir hastalıktır. Pankreasta normalde inaktif halde bulunan sindirim enzimlerinin aktif hale geçerek pankreas dokularını sindirmesi ve buna bağlı ortaya çıkan inflamasyonla karakterize bir hastalıktır. Çalışmamızda; acil servise karın ağrısı şikayeti ile başvurup Akut Pankreatit tanısı alan hastalarda Ortalama Trombosit Hacmi oranlarının seyrini izlemeyi amaçladık. and compared after all patients had been diagnosed with acute pancreatitis and regained good health. Also, the values of mean platelet volume, white blood cells and lipase were recorded twice for these patients. Results: After diagnosis and complete treatment, the mean platelet volume, white blood cells and the lipase values of 116 acute pancreatitis patients were statistically compared it was found that the values on admission were higher than after the treatment. Discussion: Mean platelet volume is an indicator that increases in acute pancreatitis so, we consider that mean platelet volume may be beneficial in the diagnosis and in monitoring the course of acute pancreatitis.
Introduction
Acute pancreatitis (AP) is a condition that may also have an effect on tissues outside of the pancreas (1) and is an inflammatory process of the pancreas, advancing with an increase in enzymes such as amylase and lipase, and with abdominal pain. Because of diagnoses followingdeath or ignorance of the diagnostic process, accurate incidence rates of AP remain unknown, but the incidence of AP is accepted as5-35/100,000 (2) . An association was found between thrombocyte activation and many diseases developing with thrombosis and inflammation (3) . Mean platelet volume (MPV) is an indicator determined by an automated blood count device as part ofa complete blood count, but is generally neglected by medical professionals. MPV was found to be associated with mean thrombocyte volumeand the function and activation of thrombocytes (4, 5) . It has been suggested that as the number of thrombocytes is generally decreased, MPV is increased, and large thrombocytes are younger and more reactive. MPV is one of the most widely used surrogate markers of platelet function and has been shown to reflect inflammatory burden and disease activity in several diseases including pre-eclampsia, acute appendicitis, unstable angina, myocardial infarction, and systemic inflammation such as ulcerative colitis and Crohn's disease (6, 7) . Studies related to the development of MPV in AP are present in the literature (8, 9) . In this studywe aimed to investigate the development of MPV values in AP patients both during the disease and after complete healing. We also investigated the course of lipase and leucocyte values with MPV, and the correlation between these values.
Material and Method
Admitted to the emergency room of Konya Training and Research Hospital, Baskent University and diagnosed with AP between March 2012 and April 2014, 116 patients were retrospectively investigated. Among the patients admitted to the emergency, those diagnosed with AP via clinical, laboratory, and radiological tests were included in the study. Those with a history of oncologic diseases, iron deficiency anemia, conditions developing with thrombocytopenia, thrombocytosis, or thalassemia, a history of metabolic diseases,orinflammatory bowel disorder were excluded from the study. Additionally, all patients were assessed according to severity classification using the Ranson's criteria; a total of 55 patients with mortality or the features of a severity classification were excluded, while those with mild to moderate severe pancreatitis (edematous and interstitial types) were included in the study. Blood samples were drawn for MPV, leucocyte count or white blood cells (WBC), and lipase from 116 patients with AP. The patients were referred to the department of gastroenterology to commence treatment. According to the standard treatment modality, intravenous fluid resuscitation, electrolyte replacement, and analgesics were administered to all patients. For those with nausea and vomiting, nasogastric drainage was performed to prevent aspiration into the respiratory tract. Total parenteral nutrition (TPN) was started to support the patients nutritionally, and antibiotherapy was started to prevent septic complications. In addition to these treatment regimes, various therapeutic methods (such as endoscopic retrograde cholangiopancreatography (ERCP) were performed due to parenchymal injuries and other complications in the pancreas to decrease mortality rate. The patients began oral feeding 5-10 days later and improvements as measured by clinical, radiological, and laboratory tests were monitored. After observing improvements, blood samples were obtained from 116 patients to evaluate the MPV, WBC, and lipase values.
Laboratory measurements
For the measurements of MPV and WBC values, an electronic routineblood count device was used (Cell-Dyne 3700, Abbott, Abbott Park, IL, USA). Routine biochemistry kits were utilized for the measurement of lipase. As expected, the results of our laboratory tests for MPV values ranged from7.0 to 12.0 fl. Statistical analysis Accumulated data were registered into previously prepared forms, and the statistical analyses were performed via SPSS 15.0 package. The data were analyzed as to appropriateness for normal distribution. For comparisons, the student's t and paired t tests were performed in dependent groups. Numeric values were defined as mean±standard deviation, and p<0.05 was accepted to be significant. While performing our analysis, we evaluated the difference between the two groups. In other words, the correlation between MPV1 during the disease period and MPV2 after amelioration was assessed in our study.
Results
Admitted to the emergency room, a total of 116 patients hospitalized in the emergency department of our hospital from March 2012 to April 2014 due to the diagnosis of AP were included into the study. Of these patients, 65 were men (56.03%) and 51 were women (43.97%). The mean age rate was detected as 61.2±3.6. In their etiology, 94 patients (81.03%) were seen to have biliary causes of AP. Twenty-two patients (18.96%) were aged 70 or over. While the mean lipase value was 1865.9±2473.6 U/L in the acute phase, it was found to be196.3±64.3 U/L in the post-disease phase. When compared, this rate was evaluated to be statistically significant (p<0.05). In terms of mean WBC values, while the rate was found to be17.74±4.85/mm3 in the acute phase, it was determined to be 8.03±1.72/mm3 after the disease period; these rates were also accepted asstatistically significant (p<0.05). Another statistically significant rate was related to mean MPV values (p<0.05), found to be7.97±1.08 fL in the acute phase and detected as 6.95±0.80 fL after amelioration (Table 1 ). In the patient group, the correlations between MPV, WBC, and lipase were evaluated, and a moderate correlation was found between MPV and lipase and MPV and WBC, although no correlation was detected between MPV1 and MPV2 values ( Table 2) . Discussion AP is an important gastroenterological emergencywith highrates of morbidity and mortality, requiring long hospital stays and with the possibility of several local and systemic complications (10). Early diagnosis and classification are of vital importance, both before and after the development of severe AP (11). However, a reliable laboratory test that diagnoses AP accurately and that can inform boththe early diagnosis and determination of the condition's etiology has yet to be found (12) . Available studies are mostly related to the determination of secondary inflammation. Levels of blood and urine amylase, serum lipase, serum elastase 1, serum trypsin, serum phospholypase A2, C-reactive protein, interleukin 6-8, and procalcitonin may be observed as increased in AP cases (13, 14) . In this study, we aimed to monitor the course of MPV, as well as WBC and lipase, during and after diagnosis of AP.
Various factors are present in the etiology of AP.Gallbladder issues and alcohol consumption are amongthe responsible factorsin 90% of cases. Among those other factors leading to AP, an increase in cholesterol level, pancreatic tumors, abdominal trauma, drugs, hypothermia, infections, ERCP, or surgical interventions are reported. In 10% of patients, however, no reasons that might causeAP are determined (15, 16) . As consistent with findings in the literature, biliary reasons leading to AP were witnessed in 81.03% of the patientsin our study.
In a study where the literature was reviewed by DiMagno et al. (17) , AP was reported to be most frequently seen in the patients' 60's. Consistent with this finding, the mean age in our study was 61.2±3.6. Because the clinical presentation of AP exhibits changeable features and there are factors restricting diagnostic procedures, sometimes difficulties may occur in the diagnosis of AP. Different parameters are used in the diagnosis and follow-up of AP. Levels of blood and urine amylase, serum lypase, serum elastase 1, serum trypsin, serum phospholypase A2, C-reactive protein, interleukin 6-8, and procalcitonin may be increased in cases of AP. The increase seen in serum lipase is more specific, compared with that in amylase. Because the increase in serum lipase continues longer than that of serum amylase, serum lipase is a more beneficial parameter in patients clinically diagnosed late. Additionally, serum lipase may also increase in such diseases as acute cholecystitis, peptic ulcer perforation, and mesentric embolism (13) . In the diagnosis of lipase-suspected AP cases, amylasin is known as the first step treatment option (18) . Also in our study, lipase values were developed at higher levels than normal during AP. AP is a disease that developswith inflammation of the pancreas as a result of the activation of enzymes of acute pancreatitis, and levels of WBC are seen as increased in such an inflammatory condition. Further, the rate of WBC>16.000/ml isa component of the Ranson's criteria and is an important marker in the determination of prognosis and the severity of AP (19) . As consistent with the literature, in our study, WBC progressionalso increased during AP. MPV is an easily measured value and a useful marker for thrombocyte function and activity. High levels of MPV usually indicate thrombocyte activity and the existence of large young thrombocytes, which are metabolically more active (4, 20) . It is accepted that there is an association between inflammation and thrombocytes. Active platelets play a key role in both inflammation and thrombosis. Hematology analyzers measure this activity with different indicators, and MPV is also one of these indicators (21, 22) . MPV is a cost-effective and cheap parameter showing platelet function and activation, which may be demonstrated in whole blood count and affected by inflammation (23) . For example, the values of MPV are affected by inflammation and acute cholecystitis (24) . In the literature, a few studies follow the course of MPV in patients with AP. In one of these studies, MPV values were detected to progress at a higher rate in AP patients compared to controls. The same study also emphasized that MPV has a positive correlation with other pancreatic enzymes (8) . In another study, MPV values were detected to be higher in severe AP, and it was considered that MPV may be a valuable marker for the prognosis of AP. Another finding was that MPV values also decreased after treatment (9) . However, in our study, MPV values displayed a higher progression in AP patients, as is consistent with literature. After the patients regained good health, MPV values were observed at normal levels, even more decreased in the patients A positive correlation was also detected between MPV values and lipase, a trypsinogen ezyme, and WBC, an indicator of inflammation.
Conclusion
In conclusion, MPV may be a beneficial marker in conjuction with others in the early diagnosis of AP in emergency rooms.
Further studies with larger sample sizes are needed to support our findings.
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